Lyme Disease Vaccine: Pfizer Launches Phase 3 Trial Targeting Kids, Adults
Pfizer on Monday said it launched the final phase of testing for a seasonal, experimental vaccine to prevent Lyme disease in people age 5 and older.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
